Market Cap ₹162 Cr.
Stock P/E 7.5
P/B 1
Current Price ₹294.4
Book Value ₹ 299
Face Value 10
52W High ₹294.4
Dividend Yield 0%
52W Low ₹ 242.3
Apis India Limited has been a significant player in the honey market since its inception in 1924. The company has grown robustly to become a leader in the organized honey trade in India. With a third-generation legacy of entrepreneurs, Apis India has extensive hands-on knowledge of the trade. The company’s state-of-the-art manufacturing facilities in Rorkee are spread over 7 acres, with a capacity to process over 100 tonnes of honey per day. Apis India’s product range has expanded beyond honey to include tea, cookies, pickles, jam, dates, and preserves, catering to the changing purchase dynamics and growing need for quality branded packaged products.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 88 | 77 | 79 | 79 | 79 | 79 | 87 | 80 | 93 | 90 |
Other Income | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 1 |
Total Income | 88 | 78 | 79 | 80 | 79 | 79 | 87 | 81 | 93 | 91 |
Total Expenditure | 82 | 71 | 71 | 72 | 66 | 73 | 80 | 72 | 84 | 79 |
Operating Profit | 7 | 6 | 8 | 8 | 13 | 6 | 7 | 9 | 9 | 12 |
Interest | 2 | 2 | 2 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
Depreciation | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 4 | 4 | 6 | 6 | 12 | 4 | 6 | 7 | 7 | 9 |
Provision for Tax | 1 | 3 | 2 | 2 | 0 | 2 | 2 | 2 | 2 | 2 |
Profit After Tax | 3 | 1 | 4 | 4 | 12 | 2 | 4 | 5 | 5 | 7 |
Adjustments | 1 | 5 | 5 | 1 | 4 | 1 | 1 | 1 | 0 | 1 |
Profit After Adjustments | 3 | 6 | 9 | 5 | 16 | 3 | 5 | 7 | 5 | 8 |
Adjusted Earnings Per Share | 6.1 | 10.4 | 16.2 | 9.2 | 28.4 | 5.4 | 9.6 | 12.2 | 9.5 | 14.7 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 196 | 225 | 210 | 273 | 295 | 332 | 316 | 350 |
Other Income | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 2 |
Total Income | 197 | 225 | 211 | 274 | 296 | 333 | 318 | 352 |
Total Expenditure | 176 | 206 | 199 | 258 | 277 | 310 | 283 | 315 |
Operating Profit | 21 | 19 | 12 | 16 | 19 | 23 | 36 | 37 |
Interest | 2 | 3 | 5 | 5 | 7 | 8 | 6 | 4 |
Depreciation | 2 | 3 | 3 | 2 | 3 | 3 | 2 | 4 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 16 | 12 | 4 | 8 | 9 | 13 | 27 | 29 |
Provision for Tax | 5 | 3 | 2 | 3 | 4 | 6 | 6 | 8 |
Profit After Tax | 11 | 9 | 2 | 5 | 6 | 7 | 22 | 21 |
Adjustments | 1 | 1 | 1 | 1 | 2 | 11 | 11 | 3 |
Profit After Adjustments | 12 | 11 | 3 | 6 | 8 | 18 | 33 | 25 |
Adjusted Earnings Per Share | 21.3 | 18.9 | 5.6 | 11.5 | 14.5 | 33.1 | 59.1 | 46 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -5% | 5% | 7% | 0% |
Operating Profit CAGR | 57% | 31% | 14% | 0% |
PAT CAGR | 214% | 64% | 20% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 28% | 152% | 74% | NA% |
ROE Average | 16% | 10% | 8% | 10% |
ROCE Average | 17% | 12% | 10% | 11% |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | 65 | 76 | 79 | 85 | 97 | 116 | 148 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 3 | 3 | 10 | 9 | 7 | 7 |
Other Non-Current Liabilities | -2 | -2 | 2 | 2 | 1 | 3 | 1 |
Total Current Liabilities | 86 | 105 | 112 | 133 | 149 | 128 | 107 |
Total Liabilities | 151 | 181 | 196 | 230 | 256 | 253 | 264 |
Fixed Assets | 14 | 14 | 14 | 12 | 12 | 12 | 13 |
Other Non-Current Assets | 4 | 10 | 22 | 22 | 26 | 43 | 44 |
Total Current Assets | 133 | 157 | 160 | 197 | 218 | 197 | 207 |
Total Assets | 151 | 181 | 196 | 230 | 256 | 253 | 264 |
#(Fig in Cr.) | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 5 | 9 | 1 | 2 | 1 | 2 | 1 |
Cash Flow from Operating Activities | 12 | 5 | 16 | -5 | 12 | 18 | -3 |
Cash Flow from Investing Activities | -8 | -7 | -9 | 2 | -4 | -9 | 8 |
Cash Flow from Financing Activities | -1 | -7 | -5 | 2 | -6 | -10 | -6 |
Net Cash Inflow / Outflow | 4 | -8 | 1 | -1 | 2 | -1 | -1 |
Closing Cash & Cash Equivalent | 9 | 1 | 2 | 1 | 2 | 1 | 1 |
# | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 21.33 | 18.9 | 5.56 | 11.53 | 14.49 | 33.13 | 59.1 |
CEPS(Rs) | 24.47 | 21.92 | 9.65 | 13.31 | 15.42 | 18.34 | 43.55 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0.4 | 0 | 0 |
Book NAV/Share(Rs) | 118.84 | 137.82 | 143.44 | 154.08 | 176.76 | 209.68 | 268.27 |
Core EBITDA Margin(%) | 10.01 | 8.18 | 5.42 | 5.58 | 6.3 | 6.7 | 10.56 |
EBIT Margin(%) | 9.45 | 7.07 | 4.27 | 4.9 | 5.57 | 6.18 | 10.5 |
Pre Tax Margin(%) | 8.4 | 5.56 | 1.96 | 2.91 | 3.1 | 3.92 | 8.6 |
PAT Margin (%) | 5.8 | 4.13 | 1.12 | 1.81 | 1.91 | 2.22 | 6.84 |
Cash Profit Margin (%) | 6.89 | 5.37 | 2.53 | 2.68 | 2.88 | 3.04 | 7.59 |
ROA(%) | 7.49 | 5.57 | 1.24 | 2.32 | 2.31 | 2.89 | 8.38 |
ROE(%) | 17.32 | 13.12 | 3.03 | 6.04 | 6.17 | 6.91 | 16.43 |
ROCE(%) | 15.4 | 12.14 | 6.29 | 8.6 | 8.98 | 10.57 | 16.74 |
Receivable days | 69.83 | 68.63 | 80.85 | 69.94 | 88.98 | 89.94 | 94.32 |
Inventory Days | 114.19 | 112.66 | 146.88 | 132.65 | 134.21 | 112.58 | 107.61 |
Payable days | 86.3 | 98.86 | 128.03 | 86.64 | 78.7 | 69.95 | 80.54 |
PER(x) | 0 | 0 | 0 | 0 | 0 | 1.94 | 3.21 |
Price/Book(x) | 0 | 0 | 0 | 0 | 0 | 0.31 | 0.71 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.26 | 0.31 | 0.33 | 0.32 | 0.35 | 0.33 | 0.52 |
EV/Core EBITDA(x) | 2.48 | 3.78 | 5.75 | 5.52 | 5.42 | 4.64 | 4.6 |
Net Sales Growth(%) | 0 | 14.87 | -6.54 | 30.17 | 8.01 | 12.44 | -4.78 |
EBIT Growth(%) | 0 | -14.12 | -43.49 | 49.11 | 22.94 | 24.74 | 61.76 |
PAT Growth(%) | 0 | -18.21 | -74.72 | 111.08 | 13.66 | 30.84 | 193.9 |
EPS Growth(%) | 0 | -11.42 | -70.56 | 107.31 | 25.59 | 128.69 | 78.41 |
Debt/Equity(x) | 0.83 | 0.87 | 0.82 | 0.97 | 1.04 | 0.64 | 0.4 |
Current Ratio(x) | 1.55 | 1.49 | 1.43 | 1.48 | 1.47 | 1.54 | 1.93 |
Quick Ratio(x) | 0.84 | 0.76 | 0.61 | 0.67 | 0.73 | 0.8 | 1.07 |
Interest Cover(x) | 8.97 | 4.68 | 1.85 | 2.46 | 2.25 | 2.73 | 5.51 |
Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 2.08 | 0.57 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 | 74.72 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 | 25.28 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 | 0.55 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About